I agree. Getting more data on risks (safety) and real-world efficacy to formulate a more comprehensive and convincing cost-benefit calculus is probably the biggest priority for far-UVC right now.
I agree. Getting more data on risks (safety) and real-world efficacy to formulate a more comprehensive and convincing cost-benefit calculus is probably the biggest priority for far-UVC right now.